Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients

Objective. To investigate the efficacy and safety of the treatment of the newly diagnosed multiple myeloma (MM) patients with the therapy of subcutaneous (subQ) administration of bortezomib and dexamethasone plus thalidomide (VTD) regimen. Methods. A total of 60 newly diagnosed MM patients were anal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biomed Res Int
Autori principali: Wu, Shenghao, Zheng, Cuiping, Chen, Songyan, Cai, Xiaoping, Shi, Yuejian, Lin, Bijing, Chen, Yuemiao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575715/
https://ncbi.nlm.nih.gov/pubmed/26425561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/927105
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi